Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Omeprazole“
Suchtreffer
Begriffe & Kennungen
Isentress · 4.5 · Co-administration of raltegravir with other agents that increase gastric pH (e.g., omeprazole and famotidine)
Eintrag öffnenIsentress · 4.5 · Co-administration of raltegravir with other agents that increase gastric pH (e.g., omeprazole and famotidine)
Eintrag öffnenIsentress · 4.5 · Co-administration of raltegravir with other agents that increase gastric pH (e.g., omeprazole and famotidine)
Eintrag öffnenJuluca · 4.5 · 10 Omeprazole AUC ↓ 14% Cmin NA Cmax ↓ 14%
Eintrag öffnenJuluca · 4.5 · Omeprazole/ Rilpivirine Rilpivirine1,2 AUC ↓ 40% Cmin ↓ 33% Cmax ↓ 40% (reduced absorption due to gastric pH i
Eintrag öffnenJylamvo · 4.5 · Co-administration of proton pump inhibitors such as omeprazole or pantoprazole can result in interactions: co-
Eintrag öffnenLumykras · 4.5 · Acid-reducing agents Co-administration of sotorasib with a PPI (omeprazole) or an H2 receptor antagonist (famo
Eintrag öffnenLumykras · 4.5 · Under fasted conditions, co-administration of multiple doses of omeprazole with a single dose of 960 mg sotora
Eintrag öffnenLumykras · 4.5 · Under fed conditions (standard-calorie moderate-fat meals), co-administration of multiple doses of omeprazole
Eintrag öffnenLydisilka · 4.5 · Based on in vitro inhibition studies and in vivo interaction studies in female volunteers using omeprazole, si
Eintrag öffnenNerlynx · 4.5 · 7 administration with proton pump inhibitors (PPIs) is not recommended (e.g. omeprazole or lansoprazole) (see
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNeupro · 4.5 · Co-administration of omeprazole (inhibitor of CYP2C19), in doses of 40 mg/day, had no effect on the pharmacoki
Eintrag öffnenNexavar · 4.5 · Concomitant administration of sorafenib and midazolam, dextromethorphan or omeprazole, which are substrates fo
Eintrag öffnenNexium Control · 4.3 · Esomeprazole must not be used concomitantly with nelfinavir or rilpivirine (see section 4.5).
Eintrag öffnenNexium Control · 4.5 · 17 Protease inhibitors Omeprazole has been reported to interact with some protease inhibitors. The clinical im
Eintrag öffnenNexium Control · 4.5 · 19 Naproxen or rofecoxib Studies evaluating concomitant administration of esomeprazole and either naproxen or
Eintrag öffnenNexium Control · 4.5 · 4 Protease inhibitors Omeprazole has been reported to interact with some protease inhibitors. The clinical imp
Eintrag öffnen